Table of Content

1 Market Overview

• 1.1 Product Definition and Market Characteristics
• 1.2 Global Subcutaneous Immunoglobulins Market Size
• 1.3 Market Segmentation
• 1.4 Global Macroeconomic Analysis
• 1.5 SWOT Analysis

2. Market Dynamics

• 2.1 Market Drivers
• 2.2 Market Constraints and Challenges
• 2.3 Emerging Market Trends
• 2.4 Impact of COVID-19
  • 2.4.1 Short-term Impact
  • 2.4.2 Long-term Impact

3 Associated Industry Assessment

• 3.1 Supply Chain Analysis
• 3.2 Industry Active Participants
  • 3.2.1 Suppliers of Raw Materials
  • 3.2.2 Key Distributors/Retailers
• 3.3 Alternative Analysis
• 3.4 The Impact of Covid-19 From the Perspective of Industry Chain

4 Market Competitive Landscape

• 4.1 Industry Leading Players
• 4.2 Industry News
  • 4.2.1 Key Product Launch News
  • 4.2.2 M&A and Expansion Plans

5 Analysis of Leading Companies

• 5.1 Kedrion S.p.A
  • 5.1.1 Kedrion S.p.A Company Profile
  • 5.1.2 Kedrion S.p.A Business Overview
  • 5.1.3 Kedrion S.p.A Subcutaneous Immunoglobulins Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.1.4 Kedrion S.p.A Subcutaneous Immunoglobulins Products Introduction
• 5.2 Octapharma AG
  • 5.2.1 Octapharma AG Company Profile
  • 5.2.2 Octapharma AG Business Overview
  • 5.2.3 Octapharma AG Subcutaneous Immunoglobulins Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.2.4 Octapharma AG Subcutaneous Immunoglobulins Products Introduction
• 5.3 LFB S.A.
  • 5.3.1 LFB S.A. Company Profile
  • 5.3.2 LFB S.A. Business Overview
  • 5.3.3 LFB S.A. Subcutaneous Immunoglobulins Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.3.4 LFB S.A. Subcutaneous Immunoglobulins Products Introduction
• 5.4 Bio Products Laboratory Ltd.
  • 5.4.1 Bio Products Laboratory Ltd. Company Profile
  • 5.4.2 Bio Products Laboratory Ltd. Business Overview
  • 5.4.3 Bio Products Laboratory Ltd. Subcutaneous Immunoglobulins Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.4.4 Bio Products Laboratory Ltd. Subcutaneous Immunoglobulins Products Introduction
• 5.5 CSL Limited
  • 5.5.1 CSL Limited Company Profile
  • 5.5.2 CSL Limited Business Overview
  • 5.5.3 CSL Limited Subcutaneous Immunoglobulins Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.5.4 CSL Limited Subcutaneous Immunoglobulins Products Introduction
• 5.6 Grifols S.A.
  • 5.6.1 Grifols S.A. Company Profile
  • 5.6.2 Grifols S.A. Business Overview
  • 5.6.3 Grifols S.A. Subcutaneous Immunoglobulins Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.6.4 Grifols S.A. Subcutaneous Immunoglobulins Products Introduction
• 5.7 Takeda Pharmaceutical Company Limited
  • 5.7.1 Takeda Pharmaceutical Company Limited Company Profile
  • 5.7.2 Takeda Pharmaceutical Company Limited Business Overview
  • 5.7.3 Takeda Pharmaceutical Company Limited Subcutaneous Immunoglobulins Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.7.4 Takeda Pharmaceutical Company Limited Subcutaneous Immunoglobulins Products Introduction
• 5.8 Biotest AG
  • 5.8.1 Biotest AG Company Profile
  • 5.8.2 Biotest AG Business Overview
  • 5.8.3 Biotest AG Subcutaneous Immunoglobulins Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.8.4 Biotest AG Subcutaneous Immunoglobulins Products Introduction

6 Market Analysis and Forecast, By Product Types

• 6.1 Global Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Types (2015-2020)
  • 6.1.1 Global Subcutaneous Immunoglobulins Sales and Market Share by Types (2015-2020)
  • 6.1.2 Global Subcutaneous Immunoglobulins Revenue and Market Share by Types (2015-2020)
  • 6.1.3 Global Subcutaneous Immunoglobulins Price by Types (2015-2020)
• 6.2 Global Subcutaneous Immunoglobulins Market Forecast by Types (2020-2025)
  • 6.2.1 Global Subcutaneous Immunoglobulins Market Forecast Sales and Market Share by Types (2020-2025)
  • 6.2.2 Global Subcutaneous Immunoglobulins Market Forecast Revenue and Market Share by Types (2020-2025)
• 6.3 Global Subcutaneous Immunoglobulins Sales, Price and Growth Rate by Types (2015-2020)
  • 6.3.1 Global Subcutaneous Immunoglobulins Sales, Price and Growth Rate of 10% Purity
  • 6.3.2 Global Subcutaneous Immunoglobulins Sales, Price and Growth Rate of 20% Purity
• 6.4 Global Subcutaneous Immunoglobulins Market Revenue and Sales Forecast, by Types (2020-2025)
  • 6.4.1 10% Purity Market Revenue and Sales Forecast (2020-2025)
  • 6.4.2 20% Purity Market Revenue and Sales Forecast (2020-2025)

7 Market Analysis and Forecast, By Applications

• 7.1 Global Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Applications (2015-2020)
  • 7.1.1 Global Subcutaneous Immunoglobulins Sales and Market Share by Applications (2015-2020)
  • 7.1.2 Global Subcutaneous Immunoglobulins Revenue and Market Share by Applications (2015-2020)
• 7.2 Global Subcutaneous Immunoglobulins Market Forecast by Applications (2020-2025)
  • 7.2.1 Global Subcutaneous Immunoglobulins Market Forecast Sales and Market Share by Applications (2020-2025)
  • 7.2.2 Global Subcutaneous Immunoglobulins Market Forecast Revenue and Market Share by Applications (2020-2025)
• 7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
  • 7.3.1 Global Subcutaneous Immunoglobulins Revenue, Sales and Growth Rate of Primary Immunodeficiency (2015-2020)
  • 7.3.2 Global Subcutaneous Immunoglobulins Revenue, Sales and Growth Rate of Secondary Immunodeficiency (2015-2020)
  • 7.3.3 Global Subcutaneous Immunoglobulins Revenue, Sales and Growth Rate of Others (2015-2020)
• 7.4 Global Subcutaneous Immunoglobulins Market Revenue and Sales Forecast, by Applications (2020-2025)
  • 7.4.1 Primary Immunodeficiency Market Revenue and Sales Forecast (2020-2025)
  • 7.4.2 Secondary Immunodeficiency Market Revenue and Sales Forecast (2020-2025)
  • 7.4.3 Others Market Revenue and Sales Forecast (2020-2025)

8 Market Analysis and Forecast, By Regions

• 8.1 Global Subcutaneous Immunoglobulins Sales by Regions (2015-2020)
• 8.2 Global Subcutaneous Immunoglobulins Market Revenue by Regions (2015-2020)
• 8.3 Global Subcutaneous Immunoglobulins Market Forecast by Regions (2020-2025)

9 North America Subcutaneous Immunoglobulins Market Analysis

• 9.1 Market Overview and Prospect Analysis
• 9.2 North America Subcutaneous Immunoglobulins Market Sales and Growth Rate (2015-2020)
• 9.3 North America Subcutaneous Immunoglobulins Market Revenue and Growth Rate (2015-2020)
• 9.4 North America Subcutaneous Immunoglobulins Market Forecast
• 9.5 The Influence of COVID-19 on North America Market
• 9.6 North America Subcutaneous Immunoglobulins Market Analysis by Country
  • 9.6.1 U.S. Subcutaneous Immunoglobulins Sales and Growth Rate
  • 9.6.2 Canada Subcutaneous Immunoglobulins Sales and Growth Rate
  • 9.6.3 Mexico Subcutaneous Immunoglobulins Sales and Growth Rate

10 Europe Subcutaneous Immunoglobulins Market Analysis

• 10.1 Market Overview and Prospect Analysis
• 10.2 Europe Subcutaneous Immunoglobulins Market Sales and Growth Rate (2015-2020)
• 10.3 Europe Subcutaneous Immunoglobulins Market Revenue and Growth Rate (2015-2020)
• 10.4 Europe Subcutaneous Immunoglobulins Market Forecast
• 10.5 The Influence of COVID-19 on Europe Market
• 10.6 Europe Subcutaneous Immunoglobulins Market Analysis by Country
  • 10.6.1 Germany Subcutaneous Immunoglobulins Sales and Growth Rate
  • 10.6.2 United Kingdom Subcutaneous Immunoglobulins Sales and Growth Rate
  • 10.6.3 France Subcutaneous Immunoglobulins Sales and Growth Rate
  • 10.6.4 Italy Subcutaneous Immunoglobulins Sales and Growth Rate
  • 10.6.5 Spain Subcutaneous Immunoglobulins Sales and Growth Rate
  • 10.6.6 Russia Subcutaneous Immunoglobulins Sales and Growth Rate

11 Asia-Pacific Subcutaneous Immunoglobulins Market Analysis

• 11.1 Market Overview and Prospect Analysis
• 11.2 Asia-Pacific Subcutaneous Immunoglobulins Market Sales and Growth Rate (2015-2020)
• 11.3 Asia-Pacific Subcutaneous Immunoglobulins Market Revenue and Growth Rate (2015-2020)
• 11.4 Asia-Pacific Subcutaneous Immunoglobulins Market Forecast
• 11.5 The Influence of COVID-19 on Asia Pacific Market
• 11.6 Asia-Pacific Subcutaneous Immunoglobulins Market Analysis by Country
  • 11.6.1 China Subcutaneous Immunoglobulins Sales and Growth Rate
  • 11.6.2 Japan Subcutaneous Immunoglobulins Sales and Growth Rate
  • 11.6.3 South Korea Subcutaneous Immunoglobulins Sales and Growth Rate
  • 11.6.4 Australia Subcutaneous Immunoglobulins Sales and Growth Rate
  • 11.6.5 India Subcutaneous Immunoglobulins Sales and Growth Rate

12 South America Subcutaneous Immunoglobulins Market Analysis

• 12.1 Market Overview and Prospect Analysis
• 12.2 South America Subcutaneous Immunoglobulins Market Sales and Growth Rate (2015-2020)
• 12.3 South America Subcutaneous Immunoglobulins Market Revenue and Growth Rate (2015-2020)
• 12.4 South America Subcutaneous Immunoglobulins Market Forecast
• 12.5 The Influence of COVID-19 on South America Market
• 12.6 South America Subcutaneous Immunoglobulins Market Analysis by Country
  • 12.6.1 Brazil Subcutaneous Immunoglobulins Sales and Growth Rate
  • 12.6.2 Argentina Subcutaneous Immunoglobulins Sales and Growth Rate
  • 12.6.3 Columbia Subcutaneous Immunoglobulins Sales and Growth Rate

13 Middle East and Africa Subcutaneous Immunoglobulins Market Analysis

• 13.1 Market Overview and Prospect Analysis
• 13.2 Middle East and Africa Subcutaneous Immunoglobulins Market Sales and Growth Rate (2015-2020)
• 13.3 Middle East and Africa Subcutaneous Immunoglobulins Market Revenue and Growth Rate (2015-2020)
• 13.4 Middle East and Africa Subcutaneous Immunoglobulins Market Forecast
• 13.5 The Influence of COVID-19 on Middle East and Africa Market
• 13.6 Middle East and Africa Subcutaneous Immunoglobulins Market Analysis by Country
  • 13.6.1 UAE Subcutaneous Immunoglobulins Sales and Growth Rate
  • 13.6.2 Egypt Subcutaneous Immunoglobulins Sales and Growth Rate
  • 13.6.3 South Africa Subcutaneous Immunoglobulins Sales and Growth Rate

14 Conclusions and Recommendations

• 14.1 Key Market Findings and Prospects
• 14.2 Advice for Investors

15 Appendix

• 15.1 Methodology
• 15.2 Research Data Source

List of Tables and Figures

Figure Product Picture

Figure Global Subcutaneous Immunoglobulins Market Size and Growth Rate 2015-2025

Table Subcutaneous Immunoglobulins Key Market Segments

Figure Global Subcutaneous Immunoglobulins Market Revenue ($) Segment by Type from 2015-2020

Figure Global Subcutaneous Immunoglobulins Market Revenue ($) Segment by Applications from 2015-2020

Table SWOT Analysis

Figure Global COVID-19 Status

Figure Supply Chain

Table Major Players Headquarters, and Service Area of Subcutaneous Immunoglobulins

Table Major Players Revenue in 2019

Figure Major Players Revenue Share in 2019

Table Kedrion S.p.A Company Profile

Table Kedrion S.p.A Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Kedrion S.p.A Production and Growth Rate

Figure Kedrion S.p.A Market Revenue ($) Market Share 2015-2020

Table Octapharma AG Company Profile

Table Octapharma AG Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Octapharma AG Production and Growth Rate

Figure Octapharma AG Market Revenue ($) Market Share 2015-2020

Table LFB S.A. Company Profile

Table LFB S.A. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure LFB S.A. Production and Growth Rate

Figure LFB S.A. Market Revenue ($) Market Share 2015-2020

Table Bio Products Laboratory Ltd. Company Profile

Table Bio Products Laboratory Ltd. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Bio Products Laboratory Ltd. Production and Growth Rate

Figure Bio Products Laboratory Ltd. Market Revenue ($) Market Share 2015-2020

Table CSL Limited Company Profile

Table CSL Limited Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure CSL Limited Production and Growth Rate

Figure CSL Limited Market Revenue ($) Market Share 2015-2020

Table Grifols S.A. Company Profile

Table Grifols S.A. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Grifols S.A. Production and Growth Rate

Figure Grifols S.A. Market Revenue ($) Market Share 2015-2020

Table Takeda Pharmaceutical Company Limited Company Profile

Table Takeda Pharmaceutical Company Limited Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Takeda Pharmaceutical Company Limited Production and Growth Rate

Figure Takeda Pharmaceutical Company Limited Market Revenue ($) Market Share 2015-2020

Table Biotest AG Company Profile

Table Biotest AG Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Biotest AG Production and Growth Rate

Figure Biotest AG Market Revenue ($) Market Share 2015-2020

Table Global Subcutaneous Immunoglobulins Sales by Types (2015-2020)

Table Global Subcutaneous Immunoglobulins Sales Share by Types (2015-2020)

Table Global Subcutaneous Immunoglobulins Revenue ($) by Types (2015-2020)

Table Global Subcutaneous Immunoglobulins Revenue Share by Types (2015-2020)

Table Global Subcutaneous Immunoglobulins Price ($) by Types (2015-2020)

Table Global Subcutaneous Immunoglobulins Market Forecast Sales by Types (2020-2025)

Table Global Subcutaneous Immunoglobulins Market Forecast Sales Share by Types (2020-2025)

Table Global Subcutaneous Immunoglobulins Market Forecast Revenue ($) by Types (2020-2025)

Table Global Subcutaneous Immunoglobulins Market Forecast Revenue Share by Types (2020-2025)

Figure Global 10% Purity Sales and Growth Rate (2015-2020)

Figure Global 10% Purity Price (2015-2020)

Figure Global 20% Purity Sales and Growth Rate (2015-2020)

Figure Global 20% Purity Price (2015-2020)

Figure Global Subcutaneous Immunoglobulins Market Revenue ($) and Growth Rate Forecast of 10% Purity (2020-2025)

Figure Global Subcutaneous Immunoglobulins Sales and Growth Rate Forecast of 10% Purity (2020-2025)

Figure Global Subcutaneous Immunoglobulins Market Revenue ($) and Growth Rate Forecast of 20% Purity (2020-2025)

Figure Global Subcutaneous Immunoglobulins Sales and Growth Rate Forecast of 20% Purity (2020-2025)

Table Global Subcutaneous Immunoglobulins Sales by Applications (2015-2020)

Table Global Subcutaneous Immunoglobulins Sales Share by Applications (2015-2020)

Table Global Subcutaneous Immunoglobulins Revenue ($) by Applications (2015-2020)

Table Global Subcutaneous Immunoglobulins Revenue Share by Applications (2015-2020)

Table Global Subcutaneous Immunoglobulins Market Forecast Sales by Applications (2020-2025)

Table Global Subcutaneous Immunoglobulins Market Forecast Sales Share by Applications (2020-2025)

Table Global Subcutaneous Immunoglobulins Market Forecast Revenue ($) by Applications (2020-2025)

Table Global Subcutaneous Immunoglobulins Market Forecast Revenue Share by Applications (2020-2025)

Figure Global Primary Immunodeficiency Sales and Growth Rate (2015-2020)

Figure Global Primary Immunodeficiency Price (2015-2020)

Figure Global Secondary Immunodeficiency Sales and Growth Rate (2015-2020)

Figure Global Secondary Immunodeficiency Price (2015-2020)

Figure Global Others Sales and Growth Rate (2015-2020)

Figure Global Others Price (2015-2020)

Figure Global Subcutaneous Immunoglobulins Market Revenue ($) and Growth Rate Forecast of Primary Immunodeficiency (2020-2025)

Figure Global Subcutaneous Immunoglobulins Sales and Growth Rate Forecast of Primary Immunodeficiency (2020-2025)

Figure Global Subcutaneous Immunoglobulins Market Revenue ($) and Growth Rate Forecast of Secondary Immunodeficiency (2020-2025)

Figure Global Subcutaneous Immunoglobulins Sales and Growth Rate Forecast of Secondary Immunodeficiency (2020-2025)

Figure Global Subcutaneous Immunoglobulins Market Revenue ($) and Growth Rate Forecast of Others (2020-2025)

Figure Global Subcutaneous Immunoglobulins Sales and Growth Rate Forecast of Others (2020-2025)

Figure Global Subcutaneous Immunoglobulins Sales and Growth Rate (2015-2020)

Table Global Subcutaneous Immunoglobulins Sales by Regions (2015-2020)

Table Global Subcutaneous Immunoglobulins Sales Market Share by Regions (2015-2020)

Figure Global Subcutaneous Immunoglobulins Sales Market Share by Regions in 2019

Figure Global Subcutaneous Immunoglobulins Revenue and Growth Rate (2015-2020)

Table Global Subcutaneous Immunoglobulins Revenue by Regions (2015-2020)

Table Global Subcutaneous Immunoglobulins Revenue Market Share by Regions (2015-2020)

Figure Global Subcutaneous Immunoglobulins Revenue Market Share by Regions in 2019

Table Global Subcutaneous Immunoglobulins Market Forecast Sales by Regions (2020-2025)

Table Global Subcutaneous Immunoglobulins Market Forecast Sales Share by Regions (2020-2025)

Table Global Subcutaneous Immunoglobulins Market Forecast Revenue ($) by Regions (2020-2025)

Table Global Subcutaneous Immunoglobulins Market Forecast Revenue Share by Regions (2020-2025)

Figure North America Subcutaneous Immunoglobulins Market Sales and Growth Rate (2015-2020)

Figure North America Subcutaneous Immunoglobulins Market Revenue and Growth Rate (2015-2020)

Figure North America Subcutaneous Immunoglobulins Market Forecast Sales (2020-2025)

Figure North America Subcutaneous Immunoglobulins Market Forecast Revenue ($) (2020-2025)

Figure North America COVID-19 Status

Figure U.S. Subcutaneous Immunoglobulins Market Sales and Growth Rate (2015-2020)

Figure Canada Subcutaneous Immunoglobulins Market Sales and Growth Rate (2015-2020)

Figure Mexico Subcutaneous Immunoglobulins Market Sales and Growth Rate (2015-2020)

Figure Europe Subcutaneous Immunoglobulins Market Sales and Growth Rate (2015-2020)

Figure Europe Subcutaneous Immunoglobulins Market Revenue and Growth Rate (2015-2020)

Figure Europe Subcutaneous Immunoglobulins Market Forecast Sales (2020-2025)

Figure Europe Subcutaneous Immunoglobulins Market Forecast Revenue ($) (2020-2025)

Figure Europe COVID-19 Status

Figure Germany Subcutaneous Immunoglobulins Market Sales and Growth Rate (2015-2020)

Figure United Kingdom Subcutaneous Immunoglobulins Market Sales and Growth Rate (2015-2020)

Figure France Subcutaneous Immunoglobulins Market Sales and Growth Rate (2015-2020)

Figure Italy Subcutaneous Immunoglobulins Market Sales and Growth Rate (2015-2020)

Figure Spain Subcutaneous Immunoglobulins Market Sales and Growth Rate (2015-2020)

Figure Russia Subcutaneous Immunoglobulins Market Sales and Growth Rate (2015-2020)

Figure Asia-Pacific Subcutaneous Immunoglobulins Market Sales and Growth Rate (2015-2020)

Figure Asia-Pacific Subcutaneous Immunoglobulins Market Revenue and Growth Rate (2015-2020)

Figure Asia-Pacific Subcutaneous Immunoglobulins Market Forecast Sales (2020-2025)

Figure Asia-Pacific Subcutaneous Immunoglobulins Market Forecast Revenue ($) (2020-2025)

Figure Asia Pacific COVID-19 Status

Figure China Subcutaneous Immunoglobulins Market Sales and Growth Rate (2015-2020)

Figure Japan Subcutaneous Immunoglobulins Market Sales and Growth Rate (2015-2020)

Figure South Korea Subcutaneous Immunoglobulins Market Sales and Growth Rate (2015-2020)

Figure Australia Subcutaneous Immunoglobulins Market Sales and Growth Rate (2015-2020)

Figure India Subcutaneous Immunoglobulins Market Sales and Growth Rate (2015-2020)

Figure South America Subcutaneous Immunoglobulins Market Sales and Growth Rate (2015-2020)

Figure South America Subcutaneous Immunoglobulins Market Revenue and Growth Rate (2015-2020)

Figure South America Subcutaneous Immunoglobulins Market Forecast Sales (2020-2025)

Figure South America Subcutaneous Immunoglobulins Market Forecast Revenue ($) (2020-2025)

Figure Brazil Subcutaneous Immunoglobulins Market Sales and Growth Rate (2015-2020)

Figure Argentina Subcutaneous Immunoglobulins Market Sales and Growth Rate (2015-2020)

Figure Columbia Subcutaneous Immunoglobulins Market Sales and Growth Rate (2015-2020)

Figure Middle East and Africa Subcutaneous Immunoglobulins Market Sales and Growth Rate (2015-2020)

Figure Middle East and Africa Subcutaneous Immunoglobulins Market Revenue and Growth Rate (2015-2020)

Figure Middle East and Africa Subcutaneous Immunoglobulins Market Forecast Sales (2020-2025)

Figure Middle East and Africa Subcutaneous Immunoglobulins Market Forecast Revenue ($) (2020-2025)

Figure UAE Subcutaneous Immunoglobulins Market Sales and Growth Rate (2015-2020)

Figure Egypt Subcutaneous Immunoglobulins Market Sales and Growth Rate (2015-2020)

Figure South Africa Subcutaneous Immunoglobulins Market Sales and Growth Rate (2015-2020)

Immunoglobulin therapy, also known as normal human immunoglobulin (NHIG), is the use of a mixture of antibodies (immunoglobulins) to treat a number of health conditions.The first description of a subcutaneous route of administration for immunoglobulin therapy dates back to 1980, but for many years subcutaneous administration was considered to be a secondary choice, only to be considered when peripheral venous access was no longer possible or tolerable.Although intravenous was the preferred route for immunoglobulin therapy for many years, in 2006 the FDA approved the first preparation of immunoglobulin that was designed exclusively for subcutaneous use.
Based on the Subcutaneous Immunoglobulins market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.

In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.

Key players in the global Subcutaneous Immunoglobulins market covered in Chapter 5:
Kedrion S.p.A
Octapharma AG
LFB S.A.
Bio Products Laboratory Ltd.
CSL Limited
Grifols S.A.
Takeda Pharmaceutical Company Limited
Biotest AG

In Chapter 6, on the basis of types, the Subcutaneous Immunoglobulins market from 2015 to 2025 is primarily split into:
10% Purity
20% Purity

In Chapter 7, on the basis of applications, the Subcutaneous Immunoglobulins market from 2015 to 2025 covers:
Primary Immunodeficiency
Secondary Immunodeficiency
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025